Literature DB >> 19151588

The Ca(v)1.4 calcium channel: more than meets the eye.

Clinton J Doering1, Jean B Peloquin, John E McRory.   

Abstract

Ca(v)1.4 channels are the latest calcium channels to be described in the literature. Originally identified in 1997 from the human genome project, several reports have since been published describing mutations in the CACNA1F gene encoding Ca(v)1.4 channels, and implicated these mutations in human disorders such as X-linked cone rod dystrophy (CORDX3) and incomplete X-linked congenital stationary night blindness type 2 (CSNB2). The gene was subsequently cloned and expressed in heterologous expression systems beginning in 2003, and many of the mutations linked to CSNB2 have been tested. Here, we review literature describing the discovery of the CACNA1F gene, its tissue expression profile, alternative splicing events, and biophysical and pharmacological characteristics of the channel in various expression systems. Channel biophysics are also compared to those obtained from recordings made from vertebrate photoreceptors, suggesting that these studies may have been describing Ca(v)1.4 channels in native cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19151588

Source DB:  PubMed          Journal:  Channels (Austin)        ISSN: 1933-6950            Impact factor:   2.581


  11 in total

1.  Voltage-activated calcium channel expression profiles in mouse brain and cultured hippocampal neurons.

Authors:  B Schlick; B E Flucher; G J Obermair
Journal:  Neuroscience       Date:  2010-02-24       Impact factor: 3.590

2.  Characterization of C-terminal Splice Variants of Cav1.4 Ca2+ Channels in Human Retina.

Authors:  Françoise Haeseleer; Brittany Williams; Amy Lee
Journal:  J Biol Chem       Date:  2016-05-17       Impact factor: 5.157

Review 3.  Calcium Channel CaVα₁ Splice Isoforms - Tissue Specificity and Drug Action.

Authors:  Diane Lipscombe; Arturo Andrade
Journal:  Curr Mol Pharmacol       Date:  2015       Impact factor: 3.339

4.  Calmodulin is a functional regulator of Cav1.4 L-type Ca2+ channels.

Authors:  Kristina Griessmeier; Hartmut Cuny; Katrin Rötzer; Oliver Griesbeck; Hartmann Harz; Martin Biel; Christian Wahl-Schott
Journal:  J Biol Chem       Date:  2009-08-28       Impact factor: 5.157

Review 5.  Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels.

Authors:  Jörg Striessnig; Hanno Jörn Bolz; Alexandra Koschak
Journal:  Pflugers Arch       Date:  2010-03-07       Impact factor: 3.657

6.  A novel large in-frame deletion within the CACNA1F gene associates with a cone-rod dystrophy 3-like phenotype.

Authors:  Jan Hauke; Andrea Schild; Antje Neugebauer; Alexandra Lappa; Julia Fricke; Sascha Fauser; Stefanie Rösler; Andrea Pannes; Dirk Zarrinnam; Janine Altmüller; Susanne Motameny; Gudrun Nürnberg; Peter Nürnberg; Eric Hahnen; Bodo B Beck
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

7.  EF hand-mediated Ca- and cGMP-signaling in photoreceptor synaptic terminals.

Authors:  Frank Schmitz; Sivaraman Natarajan; Jagadeesh K Venkatesan; Silke Wahl; Karin Schwarz; Chad P Grabner
Journal:  Front Mol Neurosci       Date:  2012-02-29       Impact factor: 5.639

Review 8.  Presynaptic [Ca(2+)] and GCAPs: aspects on the structure and function of photoreceptor ribbon synapses.

Authors:  Frank Schmitz
Journal:  Front Mol Neurosci       Date:  2014-02-06       Impact factor: 5.639

9.  Modified Ca(v)1.4 expression in the Cacna1f(nob2) mouse due to alternative splicing of an ETn inserted in exon 2.

Authors:  Clinton J Doering; Renata Rehak; Stephan Bonfield; Jean B Peloquin; William K Stell; Silvina C Mema; Yves Sauvé; John E McRory
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

10.  Dysregulation of Ca(v)1.4 channels disrupts the maturation of photoreceptor synaptic ribbons in congenital stationary night blindness type 2.

Authors:  Xiaoni Liu; Vasily Kerov; Françoise Haeseleer; Anurima Majumder; Nikolai Artemyev; Sheila A Baker; Amy Lee
Journal:  Channels (Austin)       Date:  2013-09-24       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.